200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 1000669-72-6
CAS No: 1000669-72-6 Catalog No: AG0000SX MDL No:MFCD18385006
Title | Journal |
---|---|
Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. | Journal of medicinal chemistry 20131024 |
Comprehensive analysis of kinase inhibitor selectivity. | Nature biotechnology 20111030 |
HDAC inhibitors potentiate the activity of the BCR/ABL kinase inhibitor KW-2449 in imatinib-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110515 |
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo. | Blood 20110324 |
Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. | Chemistry & biology 20101124 |
[FLT3 kinase inhibitors for the treatment of acute leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20100601 |
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. | Blood 20100218 |
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation. | Blood 20090820 |
© 2019 Angene International Limited. All rights Reserved.